You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
太極集團(600129.SH):涪陵藥廠藿香正氣口服液、急支糖漿獲得巴基斯坦准入批文
格隆匯 11-26 16:28

格隆匯11月26日丨太極集團(600129.SH)公佈,公司控股子公司太極集團重慶涪陵製藥廠有限公司(以下簡稱:涪陵藥廠)近日收到巴基斯坦藥品監督管理局衞生與非處方藥部門核准簽發的准入批文,批准公司產品藿香正氣口服液、急支糖漿可以在巴基斯坦伊斯蘭共和國(以下簡稱:巴基斯坦)銷售和使用。

藿香正氣口服液功能主治:解表化濕,理氣和中,用於外感風寒內傷濕滯或夏傷暑濕所致的感冒,症見頭痛昏重、胸膈痞悶、脘腹脹痛、嘔吐泄瀉;胃腸型感冒見上述證候者。藿香正氣口服液為公司骨幹產品之一,2018年藿香正氣口服液實現含税銷售收入11.5億元。

急支糖漿功能主治:清熱化痰,宣肺止咳。用於外感風熱所致的咳嗽,症見發熱、惡寒、胸膈滿悶、咳嗽咽痛;急性支氣管炎、慢性支氣管炎急性發作見上述證候者。急支糖漿為公司骨幹產品之一,2018年急支糖漿實現含税銷售收入3.2億元。

涪陵藥廠向巴基斯坦遞交了藿香正氣口服液、急支糖漿的准入申請,在巴基斯坦藥品監督管理局衞生與非處方藥部門舉行的第七十屆應徵評選委員會上通過審批,獲得了准入批文。截至本公告日,藿香正氣口服液已在俄羅斯、老撾、加拿大、莫桑比克、美國、馬來西亞、新加坡、文萊、印度尼西亞、泰國、柬埔寨、香港、澳門、巴基斯坦共14個國家及地區獲得註冊;急支糖漿已在印尼、香港、新加坡、美國、澳門、巴基斯坦共6個國家及地區獲得註冊。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account